Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 928-940

  Jonges, Marcel ^a,c   Liu, Wai Ming ^b,d   Van Der Vries, Erhard ^c   Jacobi, Ronald ^b   Pronk, Inge ^b   Boog, Claire ^b,e   Koopmans, Marion ^a,c   Meijer, Adam ^a   Soethout, Ernst ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FORMALDEHYDE; OSELTAMIVIR; PROPIOLACTONE; SIALIDASE INHIBITOR; TRITON X 100; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE; ZANAMIVIR;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIGENICITY; ANTIVIRAL RESISTANCE; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEAT; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS H7N3; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS INACTIVATION;

ANTIVIRAL AGENTS; CONTAINMENT OF BIOHAZARDS; DISINFECTION; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; MICROBIAL VIABILITY; MIDDLE AGED; NEURAMINIDASE; OCCUPATIONAL EXPOSURE; ORTHOMYXOVIRIDAE; VIRUS INACTIVATION;

AVES; HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 77749319428     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02045-09     Document Type: Article

References (40)

1. Bardiya, N., and J. H. Bae. 2005. Influenza vaccines: recent advances in production technologies. Appl. Microbiol. Biotechnol. 67:299-305.
2. Besselaar, T. G., D. Naidoo, A. Buys, V. Gregory, J. McAnerney, J. M. Manamela, L. Blumberg, and B. D. Schoub. 2008. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg. Infect. Dis. 14:1809-1810.
3. Bot, A., A. Reichlin, H. Isobe, S. Bot, J. Schulman, W. M. Yokoyama, and C. A. Bona. 1996. Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice. J. Virol. 70:5668-5672.
4. Claas, E. C., A. D. Osterhaus, R. van Beek, J. C. De Jong, G. F. Rimmelzwaan, D. A. Senne, S. Krauss, K. F. Shortridge, and R. G. Webster. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477.
5. De Benedictis, P., M. S. Beato, and I. Capua. 2007. Inactivation of avian influenza viruses by chemical agents and physical conditions: a review. Zoonoses Public Health 54:51-68.
6. De Flora, S., and G. Badolati. 1973. Inactivation of A2-Hong Kong influenza virus by heat and by freeze-thawing. Comparison of untreated and gamma-irradiated preparations. Boll. Ist. Sieroter. Milan. 52:293-305.
7. De Flora, S., and G. Badolati. 1973. Thermal inactivation of untreated and gamma-irradiated A2-Aichi-2-68 influenza virus. J. Gen. Virol. 20:261-265.
8. de Jong, J. C., A. M. Palache, W. E. Beyer, G. F. Rimmelzwaan, A. C. Boon, and A. D. Osterhaus. 2003. Haemagglutination-inhibiting antibody to influenza virus. Dev. Biol. (Basel) 115:63-73.
9. Dharan, N. J., L. V. Gubareva, J. J. Meyer, M. Okomo-Adhiambo, R. C. McClinton, S. A. Marshall, K. St. George, S. Epperson, L. Brammer, A. I. Klimov, J. S. Bresee, and A. M. Fry. 2009. Infections with oseltamivirresistant influenza A(H1N1) virus in the United States. JAMA 301:1034-1041.
10. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:105-117.
11. Fouchier, R. A., P. M. Schneeberger, F. W. Rozendaal, J. M. Broekman, S. A. Kemink, V. Munster, T. Kuiken, G. F. Rimmelzwaan, M. Schutten, G. J. Van Doornum, G. Koch, A. Bosman, M. Koopmans, and A. D. Osterhaus. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. U. S. A. 101:1356-1361.
12. Garten, R. J., C. T. Davis, C. A. Russell, B. Shu, S. Lindstrom, A. Balish, W. M. Sessions, X. Xu, E. Skepner, V. Deyde, M. Okomo-Adhiambo, L. Gubareva, J. Barnes, C. B. Smith, S. L. Emery, M. J. Hillman, P. Rivailler, J. Smagala, M. de Graaf, D. F. Burke, R. A. Fouchier, C. Pappas, C. M. Alpuche-Aranda, H. Lopez-Gatell, H. Olivera, I. Lopez, C. A. Myers, D. Faix, P. J. Blair, C. Yu, K. M. Keene, P. D. Dotson, Jr., D. Boxrud, A. R. Sambol, S. H. Abid, K. St. George, T. Bannerman, A. L. Moore, D. J. Stringer, P. Blevins, G. J. Demmler-Harrison, M. Ginsberg, P. Kriner, S. Waterman, S. Smole, H. F. Guevara, E. A. Belongia, P. A. Clark, S. T. Beatrice, R. Donis, J. Katz, L. Finelli, C. B. Bridges, M. Shaw, D. B. Jernigan, T. M. Uyeki, D. J. Smith, A. I. Klimov, and N. J. Cox. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
13. Goddard, N., P. Zucs, B. Ciancio, F. Plata, O. Hungnes, A. Mazick, A. Meijer, A. Hay, R. Daniels, A. Nicoll, and M. Zambon. 2009. Start of the influenza season 2008-9 in Europe-increasing influenza activity moving from West to East dominated by A(H3N2). Euro Surveill. 14:pii=19097.
14. Goldstein, M. A., and N. M. Tauraso. 1970. Effect of formalin, β-propiolactone, merthiolate, and ultraviolet light upon influenza virus infectivity, chicken cell agglutination, hemagglutination, and antigenicity. Appl. Microbiol. 19:290-294.
15. Groothuis, T. A., and J. Neefjes. 2005. The many roads to cross-presentation. J. Exp. Med. 202:1313-1318.
16. Itoh, Y., K. Shinya, M. Kiso, T. Watanabe, Y. Sakoda, M. Hatta, Y. Muramoto, D. Tamura, Y. Sakai-Tagawa, T. Noda, S. Sakabe, M. Imai, Y. Hatta, S. Watanabe, C. Li, S. Yamada, K. Fujii, S. Murakami, H. Imai, S. Kakugawa, M. Ito, R. Takano, K. Iwatsuki-Horimoto, M. Shimojima, T. Horimoto, H. Goto, K. Takahashi, A. Makino, H. Ishigaki, M. Nakayama, M. Okamatsu, K. Takahashi, D. Warshauer, P. A. Shult, R. Saito, H. Suzuki, Y. Furuta, M. Yamashita, K. Mitamura, K. Nakano, M. Nakamura, R. Brockman-Schneider, H. Mitamura, M. Yamazaki, N. Sugaya, M. Suresh, M. Ozawa, G. Neumann, J. Gern, H. Kida, K. Ogasawara, and Y. Kawaoka. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021-1025.
17. Jonges, M., I. M. van der Lubben, F. Dijkstra, L. Verhoef, M. Koopmans, and A. Meijer. 2009. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008. Antiviral Res. 83:290-297.
18. King, D. J. 1991. Evaluation of different methods of inactivation of New-castle disease virus and avian influenza virus in egg fluids and serum. Avian Dis. 35:505-514.
19. Koopmans, M., B. Wilbrink, M. Conyn, G. Natrop, H. van der Nat, H. Vennema, A. Meijer, J. van Steenbergen, R. Fouchier, A. Osterhaus, and A. Bosman. 2004. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587-593.
20. + T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. U. S. A. 103:994-999.
21. Mallard, E., F. Vernel-Pauillac, T. Velu, F. Lehmann, J. P. Abastado, M. Salcedo, and N. Bercovici. 2004. IL-2 production by virus- and tumor-specific human CD8 T cells is determined by their fine specificity. J. Immunol. 172:3963-3970.
22. McElhaney, J. E., D. Xie, W. D. Hager, M. B. Barry, Y. Wang, A. Kleppinger, C. Ewen, K. P. Kane, and R. C. Bleackley. 2006. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 176:6333-6339.
23. Meijer, A., A. Lackenby, O. Hungnes, B. Lina, S. van-der-Werf, B. Schweiger, M. Opp, J. Paget, J. van-de-Kassteele, A. Hay, and M. Zambon. 2009. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg. Infect. Dis. 15:552-560.
24. Nietert, W. C., L. M. Kellicutt, and H. Kubinski. 1974. DNA-protein complexes produced by a carcinogen, beta-propiolactone. Cancer Res. 34:859-864.
25. Peiris, M., K. Y. Yuen, C. W. Leung, K. H. Chan, P. L. Ip, R. W. Lai, W. K. Orr, and K. F. Shortridge. 1999. Human infection with influenza H9N2. Lancet 354:916-917.
26. Perrin, P., and S. Morgeaux. 1995. Inactivation of DNA by beta-propiolactone. Biologicals 23:207-211.
27. Potier, M., L. Mameli, M. Belisle, L. Dallaire, and S. B. Melancon. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferylalpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
28. Puri, A., F. P. Booy, R. W. Doms, J. M. White, and R. Blumenthal. 1990. Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment. J. Virol. 64:3824-3832.
29. Reed, L., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. (Lond.) 27:493-497.
30. Ronni, T., T. Sareneva, J. Pirhonen, and I. Julkunen. 1995. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 154:2764-2774.
31. Ruigrok, R. W., E. A. Hewat, and R. H. Wade. 1992. Low pH deforms the influenza virus envelope. J. Gen. Virol. 73(Pt. 4):995-998.
32. Sallusto, F., and A. Lanzavecchia. 2001. Exploring pathways for memory T cell generation. J. Clin. Invest. 108:805-806.
33. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
34. Smith, D. J. 2003. Applications of bioinformatics and computational biology to influenza surveillance and vaccine strain selection. Vaccine 21:1758-1761.
35. Smith, G. J., D. Vijaykrishna, J. Bahl, S. J. Lycett, M. Worobey, O. G. Pybus, S. K. Ma, C. L. Cheung, J. Raghwani, S. Bhatt, J. S. Peiris, Y. Guan, and A. Rambaut. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122-1125.
36. Swayne, D. E. 2006. Microassay for measuring thermal inactivation of H5N1 high pathogenicity avian influenza virus in naturally infected chicken meat. Int. J. Food Microbiol. 108:268-271.
37. Swayne, D. E., and J. R. Beck. 2004. Heat inactivation of avian influenza and Newcastle disease viruses in egg products. Avian Pathol. 33:512-518.
38. Thomas, C., D. J. King, and D. E. Swayne. 2008. Thermal inactivation of avian influenza and Newcastle disease viruses in chicken meat. J. Food Prot. 71:1214-1222.
39. Thomas, C., and D. E. Swayne. 2007. Thermal inactivation of H5N1 high pathogenicity avian influenza virus in naturally infected chicken meat. J. Food Prot. 70:674-680.
40. Ward, C. L., M. H. Dempsey, C. J. Ring, R. E. Kempson, L. Zhang, D. Gor, B. W. Snowden, and M. Tisdale. 2004. Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J. Clin. Virol. 29:179-188.